Michael Ha
Stock Analyst at Baird
(0.87)
# 3,812
Out of 4,944 analysts
51
Total ratings
25.81%
Success rate
-11.66%
Average return
Main Sectors:
Stocks Rated by Michael Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Downgrades: Underperform | $312 → $198 | $261.57 | -24.30% | 6 | Jul 31, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $195 → $167 | $170.48 | -2.04% | 3 | Jul 25, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $373 → $179 | $157.31 | +13.79% | 4 | Jul 25, 2025 | |
| HUM Humana | Maintains: Neutral | $300 → $297 | $274.94 | +8.02% | 6 | Jul 25, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $492 → $297 | $292.48 | +1.55% | 6 | Jul 25, 2025 | |
| CNC Centene | Maintains: Neutral | $68 → $28 | $26.17 | +6.99% | 4 | Jul 25, 2025 | |
| OSCR Oscar Health | Downgrades: Neutral | $28 → $14 | $14.98 | -6.54% | 2 | Jul 25, 2025 | |
| PRVA Privia Health Group | Maintains: Outperform | $24 → $26 | $20.71 | +25.54% | 3 | Apr 15, 2025 | |
| CVS CVS Health | Maintains: Neutral | $51 → $71 | $65.51 | +8.38% | 2 | Apr 15, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $388 → $362 | $280.47 | +29.07% | 2 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $22 | $14.64 | +50.27% | 3 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $274 → $224 | $175.21 | +27.85% | 4 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $396 → $336 | $390.31 | -13.91% | 2 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $86 → $50 | $29.10 | +71.82% | 4 | Mar 3, 2025 |
UnitedHealth Group
Jul 31, 2025
Downgrades: Underperform
Price Target: $312 → $198
Current: $261.57
Upside: -24.30%
Tenet Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $195 → $167
Current: $170.48
Upside: -2.04%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $373 → $179
Current: $157.31
Upside: +13.79%
Humana
Jul 25, 2025
Maintains: Neutral
Price Target: $300 → $297
Current: $274.94
Upside: +8.02%
Elevance Health
Jul 25, 2025
Maintains: Neutral
Price Target: $492 → $297
Current: $292.48
Upside: +1.55%
Centene
Jul 25, 2025
Maintains: Neutral
Price Target: $68 → $28
Current: $26.17
Upside: +6.99%
Oscar Health
Jul 25, 2025
Downgrades: Neutral
Price Target: $28 → $14
Current: $14.98
Upside: -6.54%
Privia Health Group
Apr 15, 2025
Maintains: Outperform
Price Target: $24 → $26
Current: $20.71
Upside: +25.54%
CVS Health
Apr 15, 2025
Maintains: Neutral
Price Target: $51 → $71
Current: $65.51
Upside: +8.38%
The Cigna Group
Apr 15, 2025
Maintains: Outperform
Price Target: $388 → $362
Current: $280.47
Upside: +29.07%
Apr 15, 2025
Maintains: Outperform
Price Target: $17 → $22
Current: $14.64
Upside: +50.27%
Apr 15, 2025
Downgrades: Neutral
Price Target: $274 → $224
Current: $175.21
Upside: +27.85%
Apr 15, 2025
Downgrades: Neutral
Price Target: $396 → $336
Current: $390.31
Upside: -13.91%
Mar 3, 2025
Maintains: Outperform
Price Target: $86 → $50
Current: $29.10
Upside: +71.82%